Search bioRxiv⌕ Search

Biology subjects

Oliveira, A. R.

Publications and source records attributed to Oliveira, A. R..

3 recordsLinked to original sources

OCTOPUS: A versatile open-source tool creating realistic numericalbrain cells

Brain cell morphology plays a crucial role in function and pathology. Biophysical models of diffusion MRI (dMRI) quantify cell morphology in vivo, enabling the design of novel biomarkers. These models represent cells by simplified geometries, such as spheres and randomly oriented cylinders, for which analytical signal expressions exist. However, dMRI signals are sensitive to morphological features, such as branching, tapering, undulation, beading, and protrusions, unaccounted for in most models, as they often render analytical solutions impossible. Simulations of the dMRI signal in synthetically generated cells offer a powerful tool to explore how microstructural morphology impacts the dMRI signal. Nevertheless, no tool to generate digital replicas of brain cells is available openly. To address this gap, we introduce the OCTOPUS toolbox, which generates cells featuring all geometrical features described above. OCTOPUS, provided via the Python interface OCTOpool, enables accessible, efficient creation of cells with complex geometries. We recreated histologically reconstructed neuronal and glial cells, including pyramidal, GABAergic and glutamatergic neurons, and astro- and microglia. To illustrate the plausibility of OCTOPUS-generated cells, we reproduced established properties of dMRI signals from brain tissue, such as the signatures of short-range disorder, branching and protrusions, and a high-b-value power law. By comparing the geometries and dMRI signals of generated and original cells, we found different growth strategies adequate for more isotropic and more anisotropic cells. We anticipate that realistic cell substrates created by OCTOPUS will help validate biophysical models, design dMRI sequences sensitive to fine-grained cell morphology beyond analytical models, and generate realistic numerical substrates of brain tissue.

neuroscience↗

Pulcherriminic acid biosynthesis and Transport: Insights from a heterologous system in Saccharomyces cerevisiae

Pulcherriminic acid is an iron chelator produced by some Kluyveromyces and Metschnikowia yeasts. Its biosynthesis is encoded by the four-gene PUL cluster, where PUL1 and PUL2 are the biosynthetic enzymes, PUL3 mediates the uptake of iron-bound pulcherrimin, and PUL4 is a putative regulator. Pulcherriminic acid holds antifungal potential, as the growth of organisms unable to uptake pulcherrimin is inhibited by deficit of essential iron. Thus, a heterologous production system to further characterize and optimize its biosynthesis would be valuable. Using our in-house yeast collection and genomes available in databases, we cloned PUL1 and PUL2 genes from K. lactis and one of our wild Metschnikowia isolates and built an effective production system in S. cerevisiae able to inhibit pathogenic growth. In this context, the K. lactis genes yielded faster pulcherriminic acid production than those from the Metschnikowia isolate and a combinatorial approach showed PUL1 to be the production bottleneck. We further showed that Pul3 is an importer of pulcherrimin, but also mediates the export of pulcherriminic acid and that the growth of pathogens like Candidozyma auris and organisms encoding PUL3 in their genome, previously called "cheaters", is inhibited by pulcherriminic acid, highlighting its potential as an antimicrobial agent.

microbiology↗

Resistance to EGFR inhibitors in lung cancer occurs through horizontal transfer and is associated with increased caveolins expression

Resistance to treatment is a major clinical problem and a major cause of cancer-related deaths. Understanding the biological basis of resistance acquisition is of utmost importance to improve the clinical management of cancer patients. NGS analysis of human lung cancer (LC) tumors from patients that relapsed after treatment with EGFR-tyrosine kinase inhibitors (TKI), revealed that the p.T790M resistance mutation is not present in all the relapsing tumor cells, suggesting that LC cells can become resistant even if not carrying the p.T790M mutation. Using in vitro treatments with conditioned medium (CM) and in vivo co-inoculation experiments, we show that LC cells sensitive to EGFR-TKIs (S cells) acquire resistance faster when treated with CM from LC cells resistant to EGFR-TKIs (R cells) or when co-inoculated with R cells in opposite flanks of the same animal. Importantly, we show that acquisition of resistance is not due to the emergence of subpopulations of cancer cells with new resistance mutations. Using transcriptomics, we show that acquisition of resistance is associated with upregulation of genes involved in endocytosis, namely caveolins CAV1 and CAV2. These findings were validated in human clinical samples, where an increase in CAV1 and CAV2 expression was associated with tumor relapse after treatment with EGFR-TKIs. Our results suggest that acquisition of resistance to targeted therapies results from the combined effect of selection of cells harboring specific resistance mutations and horizontal transfer of the resistance phenotype. These findings may pave the way to bring intercellular communication into the realm of cancer treatment. One Sentence SummaryResistance to EGFR inhibitors is transferred horizontally between lung cancer cells and is associated with gain of expression of caveolins.

cancer biology↗